Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitochondrial disorders.

Massimo Zeviani1, Valerio Carelli

  • 1Unit of Molecular Neurogenetics, National Institute of Neurology 'C. Besta', Milan, Italy. zeviani@tin.it

Current Opinion in Neurology
|September 23, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The homoplasmic MT-TK m.8357T > C mtDNA variant as a cause of multiorgan mitochondrial disease.

Mitochondrion·2025
Same author

Uncovering a Novel Pathogenic Mechanism of <i>BCS1L</i> in Mitochondrial Disorders: Insights from Functional Studies on the c.38A>G Variant.

International journal of molecular sciences·2025
Same author

De Novo <i>DNM1L</i> Pathogenic Variant Associated with Lethal Encephalocardiomyopathy-Case Report and Literature Review.

International journal of molecular sciences·2025
Same author

Study of an FBXO7 patient mutation reveals Fbxo7 and PI31 co-regulate proteasomes and mitochondria.

The FEBS journal·2024
Same author

A new family with a case of severe early-onset muscle fatigue and a peculiar maternally inherited painful swelling in chewing muscles associated with homoplasmic m.15992A>T mutation in mitochondrial tRNA<sup>Pro</sup>.

Neuromuscular disorders : NMD·2023
Same author

Structural rather than catalytic role for mitochondrial respiratory chain supercomplexes.

eLife·2023
Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026
Same journal

Editorial introduction.

Current opinion in neurology·2026
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
See all related articles

Recent advances in mitochondrial genetics challenge existing knowledge and broaden the definition of mitochondrial disease. New research, including gene therapy, offers hope for treating these complex genetic disorders.

Area of Science:

  • Mitochondrial biology and genetics
  • Molecular medicine
  • Genetic disorders

Background:

  • Mitochondrial medicine is a rapidly advancing field.
  • Over a decade of research on mitochondrial DNA defects has paved the way for new discoveries.
  • Progress is driven by advancements in genetic, biochemical, and clinical research.

Purpose of the Study:

  • To review recent contributions to mitochondrial biogenesis and disease.
  • To highlight new insights into the genetic, biochemical, and clinical aspects of mitochondrial disorders.
  • To discuss the evolving landscape of mitochondrial medicine.

Main Methods:

  • Review of recent scientific literature.
  • Integration of in-vivo, in-vitro, and in-silico approaches.

Related Experiment Videos

  • Development of animal models for mitochondrial disorders.
  • Main Results:

    • New data challenges fundamental concepts of mitochondrial DNA replication, transcription, and nuclear control.
    • Identification of nuclear genes has expanded the understanding of oxidative phosphorylation disorders.
    • Broader definition of mitochondrial disease based on new genetic findings.

    Conclusions:

    • Understanding of pathogenesis is accelerating through integrated research strategies.
    • Gene therapy research shows promise for future treatments of mitochondrial disorders.
    • Continued investigation into mitochondrial genetics and function is crucial.